This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. Advisers to the Food and Drug Administration meet next week to review drugmaker Perrigo's application to sell a decades-old pill over the counter. The two-day public meeting is one of the last steps before an FDA decision. (Perrigo via AP)
Featured Photo Galleries
